STING Agonist Plays New Role in Head and Neck Cancer Therapy
The Yale Cancer Center has discovered a new role for Stimulator of Interferon Genes (STING) in head and neck cancer treatment. While STING.
Industry News
Industry News
Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale.
Industry News
Reduced Radiation Improves Outcomes for HPV-Positive Oropharynx Cancer Patients
Oropharynx cancers that test positive for the human papillomavirus (HPV) have been rising. After radiation treatment, these patients often experience severe, lifelong swallowing,.
Industry News
Reduced Radiation Improves Outcomes for HPV-Positive Oropharynx Cancer Patients
Oropharynx cancers that test positive for the human papillomavirus (HPV) have been rising. After radiation treatment, these patients often experience severe, lifelong swallowing,.
